Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Birth defects after prenatal exposure to antiepileptic drugs.

Perucca E.

Lancet Neurol. 2005 Nov;4(11):781-6. Review.

PMID:
16239185
2.

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, Perucca E, Vajda F; EURAP study group.

Lancet Neurol. 2011 Jul;10(7):609-17. doi: 10.1016/S1474-4422(11)70107-7. Epub 2011 Jun 5.

PMID:
21652013
3.

Teratogenic effects of antiepileptic medications.

Tomson T, Battino D.

Neurol Clin. 2009 Nov;27(4):993-1002. doi: 10.1016/j.ncl.2009.06.006. Review.

PMID:
19853219
4.

Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.

Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S.

Arch Neurol. 2011 Oct;68(10):1275-81. doi: 10.1001/archneurol.2011.133. Epub 2011 Jun 13.

PMID:
21670385
5.

Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.

Tomson T, Perucca E, Battino D.

Epilepsia. 2004 Oct;45(10):1171-5.

6.

Management of epilepsy during pregnancy.

Battino D, Tomson T.

Drugs. 2007;67(18):2727-46. Review.

PMID:
18062721
7.

Use of antiepileptic drugs in pregnancy.

Tatum WO.

Expert Rev Neurother. 2006 Jul;6(7):1077-86. Review.

PMID:
16831120
8.

Comparative safety of antiepileptic drugs during pregnancy.

Hernández-Díaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, Holmes LB; North American AED Pregnancy Registry; North American AED Pregnancy Registry.

Neurology. 2012 May 22;78(21):1692-9. doi: 10.1212/WNL.0b013e3182574f39. Epub 2012 May 2.

PMID:
22551726
9.

The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.

Vajda FJ, O'Brien TJ, Hitchcock A, Graham J, Lander C.

J Clin Neurosci. 2003 Sep;10(5):543-9.

PMID:
12948456
10.

Teratogenic effects of antiepileptic drugs.

Tomson T, Battino D.

Seizure. 2008 Mar;17(2):166-71. Epub 2007 Dec 21. Review.

11.

Antiepileptic treatment in pregnant women: morphological and behavioural effects.

Tomson T, Battino D.

Handb Exp Pharmacol. 2011;205:295-315. doi: 10.1007/978-3-642-20195-0_15.

PMID:
21882118
12.

Preliminary results on pregnancy outcomes in women using lamotrigine.

Tennis P, Eldridge RR; International Lamotrigine Pregnancy Registry Scientific Advisory Committee.

Epilepsia. 2002 Oct;43(10):1161-7.

14.

Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy.

Samrén EB, van Duijn CM, Koch S, Hiilesmaa VK, Klepel H, Bardy AH, Mannagetta GB, Deichl AW, Gaily E, Granström ML, Meinardi H, Grobbee DE, Hofman A, Janz D, Lindhout D.

Epilepsia. 1997 Sep;38(9):981-90.

15.

Teratogenicity of antiepileptic drugs: state of the art.

Tomson T, Battino D.

Curr Opin Neurol. 2005 Apr;18(2):135-40. Review.

PMID:
15791143
16.

Newer anticonvulsants: lamotrigine, topiramate and gabapentin.

Holmes LB, Hernandez-Diaz S.

Birth Defects Res A Clin Mol Teratol. 2012 Aug;94(8):599-606. doi: 10.1002/bdra.23028. Epub 2012 Jun 22.

PMID:
22730257
18.

The teratogenic risk of antiepileptic drug polytherapy.

Vajda FJ, Hitchcock AA, Graham J, O'Brien TJ, Lander CM, Eadie MJ.

Epilepsia. 2010 May;51(5):805-10. doi: 10.1111/j.1528-1167.2009.02336.x. Epub 2009 Oct 8. Review.

19.

Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy.

Ornoy A.

Reprod Toxicol. 2006 Aug;22(2):214-26. Epub 2006 Apr 18. Review.

PMID:
16621443
20.

Oxcarbazepine in pregnancy: clinical experience in Argentina.

Meischenguiser R, D'Giano CH, Ferraro SM.

Epilepsy Behav. 2004 Apr;5(2):163-7.

PMID:
15123016

Supplemental Content

Support Center